Prognostic Risk Factor Evaluation in Patients With Relapsed or Refractory Multiple Myeloma Receiving Lenalidomide Treatment: Analysis of Renal Function by eGFR and of Additional Comorbidities by Comorbidity Appraisal-Reference-Cited by-同舟云学术

Prognostic Risk Factor Evaluation in Patients With Relapsed or Refractory Multiple Myeloma Receiving Lenalidomide Treatment: Analysis of Renal Function by eGFR and of Additional Comorbidities by Comorbidity Appraisal

Published:2012-02 Issue:1 Volume:12 Page:38-48
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Kleber Martina,Ihorst Gabriele,Udi Josefina,Koch Bernd,Wäsch Ralph,Engelhardt Monika

Funder

Celgene

Deutsche Krebshilfegrant

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference48 articles.

1. Pathogenesis and treatment of renal failure in multiple myeloma;Dimopoulos;Leukemia,2008

2. Renal failure in multiple myeloma;Alexanian;Arch Intern Med,1990

3. Automated Duet spot counting system and manual technologist scoring using dual-fusion fluorescence in situ hybridization (D-FISH) strategy: comparison and application to FISH minimal residual disease testing in patients with chronic myeloid leukemia;Knudson;Cancer Genet Cytogenet,2007

4. Renal failure in multiple myeloma: incidence, correlations, and prognostic significance;Eleutherakis-Papaiakovou;Leuk Lymphoma,2007

5. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002—Medical Research Council Adult Leukaemia Working Party;Augustson;J Clin Oncol,2005

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line treatment of multiple myeloma in both transplant and non-transplant candidates;Expert Review of Anticancer Therapy;2023-05-16

2. Strategien zur gemeinsamen Entscheidungsfindung in der Therapie bei Patient_innen mit onkologischen Erkrankungen;Therapeutische Umschau;2022-10

3. Geriatric assessments and frailty scores in multiple myeloma patients: a needed tool for individualized treatment?;Current Opinion in Oncology;2021-09-16

4. Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper;Journal of Geriatric Oncology;2021-05

5. The importance of serum immunoglobulin free light chain assessment for predicting outcome in patients with newly diagnosed multiple myeloma in real clinical practice;Oncohematology;2020-10-16